USANA Health Sciences, Inc.
NYSE:USNAPackaged Foods
+$0.71 today
- Market cap
- $244.42M
- Beta
- 0.77
- P/E (TTM)
- 39.6
- EPS (TTM)
- $0.48
Volume 0.15M
Average 0.12M
USNA Other Investing Activities
Investing cash flows not reported separately.
USANA Health Sciences, Inc.NYSE: USNA
Other Investing Activities · Q1 FY2026 · quarter ended Apr 2026
Other investing activities outflow grows to $0
Q1 FY2026 other investing activities was $0, compared with $0 a year earlier. Trailing-twelve-month other investing activities was $4.77M. Over 3 fiscal years it compounded at +708.4% a year.
Context
- Other investing activities amounted to 0.4% of revenue in FY2025, up 0.4 pp from a year earlier.
- Other investing activities increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly other investing activities holds near $0 or moves back toward the trailing-twelve-month quarterly average of $1.19M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Other Investing Activities history
USD · from the cash flow
- Latest · FY2025
- 3.7M USD
- Year-over-year change
- +5678.1%
- 4-year CAGR
- +130.5%
| Period | Period end | Other Investing Activities | YoY change |
|---|---|---|---|
| FY2025 | 2026-01-03 | 3.7M | +5678.1% |
| FY2024 | 2024-12-28 | 64K | +326.7% |
| FY2023 | 2023-12-31 | 15K | +114.3% |
| FY2022 | 2022-12-31 | 7K | -94.7% |
| FY2021 | 2021-12-31 | 131K | — |
Other Investing Activities vs competitors
How USNA compares with its peers on the latest reported figures
- Peers report in different currencies, so other investing activities is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +102.4% is the 2nd highest of 7, against a peer median of -108.1%.
- Other investing activities amounts to 0.5% of revenue for USNA, versus a peer median of 0.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2025 | CN¥115.68M CNY | -113.2% | -99.2% | 0.5% | |
| LTM Apr 2026 | $63.54M USD | +97660.0% | — | 3.5% | |
| LTM Mar 2026 | $25.56M USD | -170513.3% | — | 11.1% | |
| LTM Apr 2026 | $4.77M USD | +102.4% | +708.4% | 0.5% | |
WESTWestrock Coffee Company, LLC | LTM Mar 2026 | $4.51M USD | -132.7% | +29.9% | 0.4% |
| LTM Mar 2026 | R$2.6M BRL | -103.1% | -35.6% | 0.5% | |
| LTM Apr 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | -100.0% | — | 0.0% | |
| Peer median (excluding USNA) | — | -108.1% | -35.6% | 0.5% | |
Competitors are the stored peer set for USNA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Jan 2026 |
|---|---|---|---|---|---|
| Net Income | 116.51M | 69.35M | 63.79M | 42.06M | 10.76M |
| Depreciation & Amortization | 22.19M | 21.41M | 20.4M | 22.23M | 32.56M |
| Deferred Income Tax | (2.97M) | (7.18M) | (2.75M) | (6.74M) | (7.13M) |
| Stock-Based Compensation | 14.3M | 13.49M | 14.6M | 14.56M | 13.83M |
| Change in Working Capital | (28.86M) | 771K | (28M) | (13M) | (43.08M) |
| Accounts Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | (10.5M) | 15.8M | 2.35M | (2.12M) | (34.69M) |
| Accounts Payables | (4.57M) | (2.66M) | (428K) | (1.27M) | 5.2M |
| Other Working Capital | (13.79M) | (12.37M) | (29.92M) | (9.62M) | (13.6M) |
| Other Non-Cash Items | 61K | 6.07M | 2.61M | 1.89M | 15.41M |
| Operating Cash Flow | 121.23M | 103.9M | 70.64M | 60.99M | 22.35M |
| Capital Expenditures | (12.76M) | (10.4M) | (14.49M) | (10.07M) | (13.82M) |
| Acquisitions (Net) | (1.94M) | (6.53M) | 0 | (203.34M) | 0 |
| Purchases of Investments | (1.56M) | 0 | (1.27M) | (870K) | 0 |
| Sales of Investments | 1.94M | 4.56M | 3.78M | 1.13M | 0 |
| Other Investing Activities | 131K | 7K | 15K | 64K | 3.7M |
| Investing Cash Flow | (14.19M) | (12.37M) | (11.98M) | (213.09M) | (10.13M) |
| Debt Repayment | 0 | 0 | 792K | 22.22M | (9M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (177.84M) | (25.38M) | (11.6M) | (9.44M) | (27.51M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (3.58M) | (4.71M) | (3.43M) | (3.22M) | (4.1M) |
| Financing Cash Flow | (181.41M) | (30.09M) | (14.24M) | 9.55M | (40.6M) |
| Effect of Forex Changes | 2.09M | (13.78M) | (2.5M) | (6.19M) | 5.11M |
| Net Change in Cash | (72.28M) | 47.67M | 41.93M | (148.74M) | (23.27M) |
| Free Cash Flow | 108.46M | 93.5M | 56.15M | 50.92M | 8.53M |
USANA Health Sciences, Inc.
NYSE:USNA
Intrinsic Alpha fair value
Locked
Current Price
$13.22
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.